CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

Clinical trial NCT03263208 · UNKNOWN

Trial details

NCT number: NCT03263208
Sponsor: Henan Cancer Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphocytic Leukemia

Start date: 2017-08-16
Primary completion: 2019-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.